In vitro maintenance and retroviral transduction of human myeloma cells in long-term marrow cultures

Cancer Gene Therapy

Volumn 4, Issue 3, 1997, Pages 148-156

  Stewart, A Keith ^a,b,e   Prince, H Miles ^a,b   Cappe, Darrin ^a   Chu, Peter ^c   Lutzko, Carolyn ^c   Robert Sutherland, D ^a,b   Dubé, Ian D ^a,b,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Gene marking; Marrow culture; Myeloma; Retrovirus

Indexed keywords

ALKYLATING AGENT; MELPHALAN;

ARTICLE; BONE MARROW CELL; CELL CLONE; CELL CULTURE; CELL SURVIVAL; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; EVALUATION; GENE TRANSFER; GENE VECTOR; GENETIC MARKER; GENETICS; HEMATOPOIETIC STEM CELL; HUMAN; METHODOLOGY; MOLONEY LEUKEMIA ONCOVIRUS; MULTIPLE MYELOMA; PATHOLOGY; PLASMA CELL; TIME;

ANTINEOPLASTIC AGENTS, ALKYLATING; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CLONE CELLS; EVALUATION STUDIES; GENE TRANSFER TECHNIQUES; GENETIC MARKERS; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; MELPHALAN; MOLONEY MURINE LEUKEMIA VIRUS; MULTIPLE MYELOMA; PLASMA CELLS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0031133362     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Miller AD, Skotzko MJ, Rhoades K, et al. Simultaneous use of two retroviral vectors in human gene marking trials: feasibility and potential applications. Hum Gene Ther. 1992;3:619-624.
2. Stewart AK, Dubé ID. Monitoring cancer relapse with retroviral gene marked autologous blood or bone marrow cells. What have we learned and what next? Gene Ther. 1995;2:590-591.
3. Brenner MK, Rill DR, Moen RC, et al. Gene marking to trace origin of relapse after autologous bone marrow transplantation for acute myelogenous leukemia. Lancet. 1993;341:85-90.
4. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML, Blood. 1994;83:3068-3076.
5. Brenner MK, Ril DR, Holladay MS, et al. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet. 1993; 342:1134-1137.
6. Gribben JG, Freedman AS, Neuberg D, et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B cell lymphoma. N Engl J Med. 1991;22:1525-1530.
7. Attal M, Haroussea JL, Stoppa AM, et al. A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med. 1996;335:91-97.
8. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood. 1995;85:3048-3057.
9. Bjorkstrand B, Gahrton G, Dilber MS, et al. Retroviral-mediated gene transfer of CD34-enriched bone marrow and peripheral blood cells during autologous stem cell transplantation for multiple myeloma. Hum Gene Ther. 1994;5:1279-1286.
10. Stewart AK, Dubé ID, Kamel-Reid S, Keating A. A phase 1 study of autologous bone marrow transplantation with stem cell gene marking in multiple myeloma. Hum Gene Ther. 1995;6:107-119.
11. Carter RF, Abrams-Ogg ACG, Dick JE, et al. Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors. Blood. 1992;79: 356-364.
12. Bienzle D, Abrams-Ogg ACG, Kruth SA, et al. Gene transfer into hematopoietic stem-cells: long-term maintenance of in vitro activated progenitors without marrow ablation. Proc Natl Acad Sci USA. 1994;91:350-354.
13. Sutherland HJ, Eaves CJ, Eaves AC, et al. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood. 1989;74:1563-1570.
14. Eaves CJ, Cashman JD, Kay RJ, et al. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood. 1991;78:110-117.
15. Cashman J, Eaves AC, Eaves CJ. Regulated proliferation of primitive hematopoietic progenitor cells in long-term human marrow cultures. Blood. 1985;66:1002-1005.
16. Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol. 1976;91:335-344.
17. Caligaris-Cappio F, Bergui L, Gregoretti MG, et al. Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood. 1991;77:2688-2693.
18. Visani G, Lemoli RM, Dinota A, et al. Evidence that long-term bone marrow culture of patients with multiple myeloma favors normal hemopoietic proliferation. Transplantation. 1989;48:1026-1031.
19. Farag SS, Firkin FC. Clonally rearranged antigen receptor gene DNA studies in evalulation of susceptibility of neoplastic lymphocytic and plasmacytic disorders to selective loss in long-term marrow culture. Leukemia. 1994;8:1369-1374.
20. Berneman ZN, Chen Z, Ramael M, et al. Human long-term marrow cultures (HLTBMCs) in myelomatous disorders. Leukemia. 1989;3:151-154.
21. Caligaris-Cappio F, Gregoretti MG, Ghia P, Bergui L. In vitro growth of human multiple myeloma: implications for biology and therapy. Hematol Oncol Clin North Am. 1992; 6:257-271.
22. Lokhorst HM, Lamme T, de Smet M, et al. Primary tumor cells of myeloma patients induced interleukin-6 secretion in long-term bone marrow cultures. Blood. 1994;84:2269-2277.
23. McGinnes K, Quesniaux V, Hitzler J, Paige C. Human B-lymphopoiesis is supported by bone marrow-derived stromal cells. Exp Hematol. 1991;19:294-303.
24. Dick JE, Kamel-Reid S, Murdoch B, Doedens M. Gene transfer into normal human hematopoietic cells using in vitro and in vivo assays. Blood. 1991;78:624-634.
25. Deane M, McCarthy KP, Wiedemann LM, Norton JD. An improved method for detection of B-lymphoid clonality by polymerase chain reaction. Leukemia. 1991;5:726-730.
26. Dersimonian H, Schwartz RS, Barrett KJ, Stollar BD. Relationship of human variable region heavy chain germ-line genes to genes encoding anti-DNA antibodies. J Immunol. 1987;139:2496-2501.
27. Manniatis T, Fritsch EF, Sambrook J. Molecular cloning. In: A Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 19•.
28. Dubé ID, Eaves CJ, Kalousek D, Eaves AC. A method for obtaining high quality chromosome preparations from single hemopoietic colonies on a routine basis. Cancer Genet Cytogenet. 1981;4:157-168.
29. Carter RF, Kruth SA, Valli, V, Dubé ID. Long-term culture of canine marrow: cytogenetic evaluation of purging of lymphoma and leukemia. Exp Hematol. 1990;18: 995-1001.
30. Dubé ID, Abrams-Ogg ACG, Kamel-Reid S, et al. Preclinical assessment of gene transfer of hematopoietic progenitor cells in human long term marrow cultures. Hum Gene Ther. 1996;7:2089-2100.
31. Touw I, Lowenberg B. Production of T lymphocyte colony-forming units from precursors in human long-term bone marrow cultures. Blood. 1984;64:656-661.
32. Berneman ZN, Chen Z, van Bockstaele D, et al. The nature of the adherent hematopoietic cells in human long-term bone marrow cultures: presence of lymphocytes and plasma cells next to the myelomonocytic population. Leukemia. 1989;3:648-661.
33. Firkin FC, Birner R, Russell SH, Garson OM. Contrasting patterns of neoplastic cell behaviour in long-term culture of bone marrow from patients with acute leukemia and myelodysplastic disorders. Br J Haematol. 1990;75:476-484.
34. Coulombel L, Eaves C, Kalousek D, et al. Long-term marrow culture of cells from patients with acute myelogenous leukemia. J Clin Invest. 1985;75:961-969.
35. Chang J, Morgenstern GR, Coutinho LH, et al. The use of bone marrow cells grown in long-term culture for autologous bone marrow transplantation in acute myeloid leukemia: an update. Bone Marrow Transplant. 1989;4:5-9.
36. Barnett MJ, Eaves CJ, Phillips GL, et al. Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study. Blood. 1994;84:724-732.
37. Coulombel L, Kalousek D, Eaves CJ, et al. Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. N Engl J Med. 1983;308:1493-1498.
38. Dubé ID, Kalousek D, Coulombel L, et al. Cytogenetic studies of early myeloid progenitor compartments in Phpositive chronic myeloid leukemia. II. Long-term culture reveals the persistence of Ph-negative progenitors in treated as well as newly diagnosed patients. Blood. 1984; 63:1172-1177.
39. Bjorkstrand B, Dilber MS, Smith CIE, et al. Retroviral-mediated gene transfer into human myeloma cells. Br J Haematol. 1994;88:325-331.
40. Tricot G, Jagannath S, Vesole DH, et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood. 1995;85:588-596.
41. Prince HM, Imrie K, Sutherland DR, et al. Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections. Br J Haematol. 1996;92:142-145.